{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:58:45Z","timestamp":1791579525105,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T00:00:00Z","timestamp":1417996800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature Chem"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1038\/nchem.2129","type":"journal-article","created":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T13:15:43Z","timestamp":1418044543000},"page":"73-81","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":284,"title":["Screening and classifying small-molecule inhibitors of amyloid formation using ion mobility spectrometry\u2013mass spectrometry"],"prefix":"10.1038","volume":"7","author":[{"given":"Lydia M.","family":"Young","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet C.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel A.","family":"Mahood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte H.","family":"Revill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Hsien","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Raleigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena E.","family":"Radford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison E.","family":"Ashcroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,8]]},"reference":[{"key":"BFnchem2129_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3109\/13506129.2012.734345","volume":"19","author":"JD Sipe","year":"2012","unstructured":"Sipe, J. D. et al. Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid 19, 167\u2013170 (2012).","journal-title":"Amyloid"},{"key":"BFnchem2129_CR2","doi-asserted-by":"publisher","first-page":"5656","DOI":"10.1021\/ja311729d","volume":"135","author":"NP Grimster","year":"2013","unstructured":"Grimster, N. P. et al. Aromatic sulfonyl fluorides covalently kinetically stabilize transthyretin to prevent amyloidogenesis while affording a fluorescent conjugate. J. Am. Chem. Soc. 135, 5656\u20135668 (2013).","journal-title":"J. Am. Chem. Soc."},{"key":"BFnchem2129_CR3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/74082","volume":"7","author":"T Klabunde","year":"2000","unstructured":"Klabunde, T. et al. Rational design of potent human transthyretin amyloid disease inhibitors. Nature Struct. Mol. Biol. 7, 312\u2013321 (2000).","journal-title":"Nature Struct. Mol. Biol."},{"key":"BFnchem2129_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.sbi.2009.12.009","volume":"20","author":"S Connelly","year":"2010","unstructured":"Connelly, S., Choi, S., Johnson, S. M., Kelly, J. W. & Wilson, I. A. Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses. Curr. Opin. Struct. Biol. 20, 54\u201362 (2010).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"BFnchem2129_CR5","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.tibtech.2013.05.004","volume":"31","author":"Z Hamrang","year":"2013","unstructured":"Hamrang, Z., Rattray, N. J. W. & Pluen, A. Proteins behaving badly: emerging technologies in profiling biopharmaceutical aggregation. Trends Biotech. 31, 448\u2013458 (2013).","journal-title":"Trends Biotech."},{"key":"BFnchem2129_CR6","doi-asserted-by":"publisher","first-page":"E1317","DOI":"10.1152\/ajpendo.00082.2006","volume":"291","author":"JJ Meier","year":"2006","unstructured":"Meier, J. J. et al. Inhibition of human IAPP fibril formation does not prevent \u03b2-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP. Am. J. Physiol. Endocrinol. Metab. 291, E1317\u2013E1324 (2006).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnchem2129_CR7","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1042\/bj20030422","volume":"374","author":"JF Aitken","year":"2003","unstructured":"Aitken, J. F., Loomes, K. M., Konarkowska, B. & Cooper, G. J. S. Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid. Biochem. J. 374, 779\u2013784 (2003).","journal-title":"Biochem. J."},{"key":"BFnchem2129_CR8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0014-5793(01)02972-6","volume":"507","author":"TA Harroun","year":"2001","unstructured":"Harroun, T. A., Bradshaw, J. P. & Ashley, R. H. Inhibitors can arrest the membrane activity of human islet amyloid polypeptide independently of amyloid formation. FEBS Lett. 507, 200\u2013204 (2001).","journal-title":"FEBS Lett."},{"key":"BFnchem2129_CR9","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nchembio.635","volume":"7","author":"LA Woods","year":"2011","unstructured":"Woods, L. A. et al. Ligand binding to distinct states diverts aggregation of an amyloid-forming protein. Nature Chem. Biol. 7, 730\u2013739 (2011).","journal-title":"Nature Chem. Biol."},{"key":"BFnchem2129_CR10","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1021\/ja406831n","volume":"136","author":"LM Young","year":"2014","unstructured":"Young, L. M., Cao, P., Raleigh, D. P., Ashcroft, A. E. & Radford, S. E. Ion mobility spectrometry\u2013mass spectrometry defines the oligomeric intermediates in amylin amyloid formation and the mode of action of inhibitors. J. Am. Chem. Soc. 136, 660\u2013670 (2014).","journal-title":"J. Am. Chem. Soc."},{"key":"BFnchem2129_CR11","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1073\/pnas.1220326110","volume":"110","author":"SJ Hyung","year":"2013","unstructured":"Hyung, S. J. et al. Insights into antiamyloidogenic properties of the green tea extract (\u2013)-epigallocatechin-3-gallate toward metal-associated amyloid-\u03b2 species. Proc. Natl Acad. Sci. USA 110, 3743\u20133748 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnchem2129_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3109\/03009734.2011.573884","volume":"116","author":"P Westermark","year":"2011","unstructured":"Westermark, P. Amyloid in the islets of Langerhans: thoughts and some historical aspects. Ups. J. Med. Sci. 116, 81\u201389 (2011).","journal-title":"Ups. J. Med. Sci."},{"key":"BFnchem2129_CR13","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","volume":"81","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe, D. J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81, 741\u2013766 (2001).","journal-title":"Physiol. Rev."},{"key":"BFnchem2129_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nchembio.65","volume":"4","author":"BY Feng","year":"2008","unstructured":"Feng, B. Y. et al. Small-molecule aggregates inhibit amyloid polymerization. Nature Chem. Biol. 4, 197\u2013199 (2008).","journal-title":"Nature Chem. Biol."},{"key":"BFnchem2129_CR15","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.1073\/pnas.0910723107","volume":"107","author":"J Bieschke","year":"2010","unstructured":"Bieschke, J. et al. EGCG remodels mature \u03b1-synuclein and amyloid-\u03b2 fibrils and reduces cellular toxicity. Proc. Natl Acad. Sci. USA 107, 7710\u20137715 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnchem2129_CR16","doi-asserted-by":"publisher","first-page":"8127","DOI":"10.1021\/bi100939a","volume":"49","author":"F Meng","year":"2010","unstructured":"Meng, F., Abedini, A., Plesner, A., Verchere, C. B. & Raleigh, D. P. The flavanol (\u2013)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity. Biochemistry 49, 8127\u20138133 (2010).","journal-title":"Biochemistry"},{"key":"BFnchem2129_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0014-5793(97)01290-8","volume":"417","author":"D Howlett","year":"1997","unstructured":"Howlett, D., Cutler, P., Heales, S. & Camilleri, P. Hemin and related porphyrins inhibit \u03b2-amyloid aggregation. FEBS Lett. 417, 249\u2013251 (1997).","journal-title":"FEBS Lett."},{"key":"BFnchem2129_CR18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jmb.2010.12.028","volume":"406","author":"F Meng","year":"2010","unstructured":"Meng, F. & Raleigh, D. P. Inhibition of glycosaminoglycan-mediated amyloid formation by islet amyloid polypeptide and proIAPP processing intermediates. J. Mol. Biol. 406, 491\u2013502 (2010).","journal-title":"J. Mol. Biol."},{"key":"BFnchem2129_CR19","doi-asserted-by":"publisher","first-page":"14454","DOI":"10.1021\/bi048582a","volume":"43","author":"Y Porat","year":"2004","unstructured":"Porat, Y., Mazor, Y., Efrat, S. & Gazit, E. Inhibition of islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions. Biochemistry 43, 14454\u201314462 (2004).","journal-title":"Biochemistry"},{"key":"BFnchem2129_CR20","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nsmb.1437","volume":"15","author":"DE Ehrnhoefer","year":"2008","unstructured":"Ehrnhoefer, D. E. et al. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nature Struct. Mol. Biol. 15, 558\u2013566 (2008).","journal-title":"Nature Struct. Mol. Biol."},{"key":"BFnchem2129_CR21","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.jasms.2006.05.005","volume":"17","author":"T Daubenfeld","year":"2006","unstructured":"Daubenfeld, T., Bouin, A. P. & van der Rest, G. A deconvolution method for the separation of specific versus nonspecific interactions in noncovalent protein\u2013ligand complexes analyzed by ESI-FT-ICR mass spectrometry. J. Am. Soc. Mass Spectrom. 17, 1239\u20131248 (2006).","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"BFnchem2129_CR22","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.jasms.2009.02.024","volume":"20","author":"N Sun","year":"2009","unstructured":"Sun, N., Sun, J., Kitova, E. N. & Klassen, J. S. Identifying nonspecific ligand binding in electrospray ionization mass spectrometry using the reporter molecule method. J. Am. Soc. Mass Spectrom. 20, 1242\u20131250 (2009).","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"BFnchem2129_CR23","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1021\/ac0522005","volume":"78","author":"J Sun","year":"2006","unstructured":"Sun, J., Kitova, E. N., Wang, W. & Klassen, J. S. Method for distinguishing specific from nonspecific protein\u2013ligand complexes in nanoelectrospray ionization mass spectrometry. Anal. Chem. 78, 3010\u20133018 (2006).","journal-title":"Anal. Chem."},{"key":"BFnchem2129_CR24","doi-asserted-by":"publisher","first-page":"4945","DOI":"10.1021\/ac034300l","volume":"75","author":"W Wang","year":"2003","unstructured":"Wang, W., Kitova, E. N. & Klassen, J. S. Influence of solution and gas phase processes on protein\u2013carbohydrate binding affinities determined by nanoelectrospray Fourier transform ion cyclotron resonance mass spectrometry. Anal. Chem. 75, 4945\u20134955 (2003).","journal-title":"Anal. Chem."},{"key":"BFnchem2129_CR25","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jmb.2010.05.001","volume":"400","author":"F Meng","year":"2010","unstructured":"Meng, F. et al. The sulfated triphenyl methane derivative acid fuchsin is a potent inhibitor of amyloid formation by human islet amyloid polypeptide and protects against the toxic effects of amyloid formation. J. Mol. Biol. 400, 555\u2013566 (2010).","journal-title":"J. Mol. Biol."},{"key":"BFnchem2129_CR26","doi-asserted-by":"publisher","first-page":"18283","DOI":"10.1021\/ja903814q","volume":"131","author":"NF Dupuis","year":"2009","unstructured":"Dupuis, N. F., Wu, C., Shea, J. E. & Bowers, M. T. Human islet amyloid polypeptide monomers form ordered beta-hairpins: a possible direct amyloidogenic precursor. J. Am. Chem. Soc. 131, 18283\u201318292 (2009).","journal-title":"J. Am. Chem. Soc."},{"key":"BFnchem2129_CR27","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.bbrc.2012.02.042","volume":"419","author":"B Cheng","year":"2012","unstructured":"Cheng, B. et al. Silibinin inhibits the toxic aggregation of human islet amyloid polypeptide. Biochem. Biophys. Res. Commun. 419, 495\u2013499 (2012).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnchem2129_CR28","doi-asserted-by":"publisher","first-page":"22715","DOI":"10.1074\/jbc.M011499200","volume":"276","author":"R Khurana","year":"2001","unstructured":"Khurana, R., Uversky, V. N., Nielsen, L. & Fink, A. L. Is Congo red an amyloid-specific dye? J. Biol. Chem. 276, 22715\u201322721 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnchem2129_CR29","doi-asserted-by":"publisher","first-page":"10842","DOI":"10.1074\/jbc.M212540200","volume":"278","author":"YS Kim","year":"2003","unstructured":"Kim, Y. S., Randolph, T. W., Manning, M. C., Stevens, F. J. & Carpenter, J. F. Congo red populates partially unfolded states of an amyloidogenic protein to enhance aggregation and amyloid fibril formation. J. Biol. Chem. 278, 10842\u201310850 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnchem2129_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1747-0285.2005.00318.x","volume":"67","author":"Y Porat","year":"2006","unstructured":"Porat, Y., Abramowitz, A. & Gazit, E. Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem. Biol. Drug. Des. 67, 27\u201337 (2006).","journal-title":"Chem. Biol. Drug. Des."},{"key":"BFnchem2129_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1055\/s-2003-37493","volume":"111","author":"T Thomas","year":"2003","unstructured":"Thomas, T., Nadackal, G. T. & Thomas, K. Aspirin and diabetes: inhibition of amylin aggregation by nonsteroidal anti-inflammatory drugs. Exp. Clin. Endocrinol. Diabetes 111, 8\u201311 (2003).","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"BFnchem2129_CR32","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nchembio.635","volume":"7","author":"LA Woods","year":"2011","unstructured":"Woods, L. A. et al. Ligand binding to distinct states diverts aggregation of an amyloid-forming protein. Nature Chem. Biol. 7, 730\u2013739 (2011).","journal-title":"Nature Chem. Biol."},{"key":"BFnchem2129_CR33","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1021\/bi2015162","volume":"51","author":"P Cao","year":"2012","unstructured":"Cao, P. & Raleigh, D. P. Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols. Biochemistry 51, 2670\u20132683 (2012).","journal-title":"Biochemistry"},{"key":"BFnchem2129_CR34","doi-asserted-by":"publisher","first-page":"7503","DOI":"10.1021\/ja3115696","volume":"135","author":"FL Palhano","year":"2013","unstructured":"Palhano, F. L., Lee, J., Grimster, N. P. & Kelly, J. W. Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils. J. Am. Chem. Soc. 135, 7503\u20137510 (2013).","journal-title":"J. Am. Chem. Soc."},{"key":"BFnchem2129_CR35","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1006\/jmbi.1999.3422","volume":"295","author":"K Tenidis","year":"2000","unstructured":"Tenidis, K. et al. Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties. J. Mol. Biol. 295, 1055\u20131071 (2000).","journal-title":"J. Mol. Biol."},{"key":"BFnchem2129_CR36","doi-asserted-by":"publisher","first-page":"16742","DOI":"10.1073\/pnas.262663499","volume":"99","author":"AT Petkova","year":"2002","unstructured":"Petkova, A. T. et al. A structural model for Alzheimer's \u03b2-amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl Acad. Sci. USA 99, 16742\u201316747 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnchem2129_CR37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s12127-012-0115-z","volume":"16","author":"L Young","year":"2013","unstructured":"Young, L. et al. Monitoring oligomer formation from self-aggregating amylin peptides using ESI-IMS-MS. Int. J. Ion Mobil. Spectrom. 16, 29\u201339 (2013).","journal-title":"Int. J. Ion Mobil. Spectrom."},{"key":"BFnchem2129_CR38","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2174\/156720507781788882","volume":"4","author":"P Aisen","year":"2007","unstructured":"Aisen, P. et al. Alzhemed: a potential treatment for Alzheimer's disease. Curr. Alzheimer Res. 4, 473\u2013478 (2007).","journal-title":"Curr. Alzheimer Res."},{"key":"BFnchem2129_CR39","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.neurobiolaging.2006.02.015","volume":"28","author":"F Gervais","year":"2007","unstructured":"Gervais, F. et al. Targeting soluble A\u03b2 peptide with tramiprosate for the treatment of brain amyloidosis. Neurobiol. Aging 28, 537\u2013547 (2007).","journal-title":"Neurobiol. Aging"},{"key":"BFnchem2129_CR40","doi-asserted-by":"publisher","first-page":"10311","DOI":"10.1074\/jbc.M608207200","volume":"282","author":"M Necula","year":"2007","unstructured":"Necula, M., Kayed, R., Milton, S. & Glabe, C. G. Small molecule inhibitors of aggregation indicate that amyloid \u03b2 oligomerization and fibrillization pathways are independent and distinct. J. Biol. Chem. 282, 10311\u201310324 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFnchem2129_CR41","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S1359-6446(00)01517-8","volume":"5","author":"MJ Valler","year":"2000","unstructured":"Valler, M. J. & Green, D. Diversity screening versus focussed screening in drug discovery. Drug Discov. Today 5, 286\u2013293 (2000).","journal-title":"Drug Discov. Today"},{"key":"BFnchem2129_CR42","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1096\/fj.04-1764com","volume":"18","author":"FG De Felice","year":"2004","unstructured":"De Felice, F. G. et al. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of A\u03b2 oligomerization. FASEB J. 18, 1366\u20131372 (2004).","journal-title":"FASEB J."},{"key":"BFnchem2129_CR43","doi-asserted-by":"publisher","first-page":"24228","DOI":"10.1074\/jbc.M110.133108","volume":"285","author":"ARA Ladiwala","year":"2010","unstructured":"Ladiwala, A. R. A. et al. Resveratrol selectively remodels soluble oligomers and fibrils of amyloid A\u03b2 into off-pathway conformers. J. Biol. Chem. 285, 24228\u201324237 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnchem2129_CR44","doi-asserted-by":"publisher","first-page":"5892","DOI":"10.1074\/jbc.M404751200","volume":"280","author":"F Yang","year":"2005","unstructured":"Yang, F. et al. Curcumin inhibits formation of amyloid \u03b2 oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem. 280, 5892\u20135901 (2005).","journal-title":"J. Biol. Chem."},{"issue":"6","key":"BFnchem2129_CR45","doi-asserted-by":"publisher","first-page":"e11101","DOI":"10.1371\/journal.pone.0011101","volume":"5","author":"Roni Scherzer-Attali","year":"2010","unstructured":"Scherzer-Attali, R. et al. Complete phenotypic recovery of an Alzheimer's disease model by a quinone\u2013tryptophan hybrid aggregation inhibitor. PLoS ONE 5, e11101 (2010).","journal-title":"PLoS ONE"},{"key":"BFnchem2129_CR46","unstructured":"Rapid Overlay of Chemical Structures (OpenEye, Scientific Software, Santa Fe, New Mexico, 2007)."},{"key":"BFnchem2129_CR47","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.1021\/ol101981b","volume":"12","author":"P Marek","year":"2010","unstructured":"Marek, P., Woys, A. M., Sutton, K., Zanni, M. T. & Raleigh, D. P. Efficient microwave-assisted synthesis of human islet amyloid polypeptide designed to facilitate the specific incorporation of labeled amino acids. Org. Lett. 12, 4848\u20134851 (2010).","journal-title":"Org. Lett."},{"key":"BFnchem2129_CR48","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1002\/rcm.1641","volume":"18","author":"K Giles","year":"2004","unstructured":"Giles, K. et al. Applications of a travelling wave-based radio-frequency-only stacked ring ion guide. Rapid Commun. Mass Spectrom. 18, 2401\u20132414 (2004).","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"BFnchem2129_CR49","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jmb.2008.01.092","volume":"378","author":"GW Platt","year":"2008","unstructured":"Platt, G. W., Routledge, K. E., Homans, S. W. & Radford, S. E. Fibril growth kinetics reveal a region of beta2-microglobulin important for nucleation and elongation of aggregation. J. Mol. Biol. 378, 251\u2013263 (2008).","journal-title":"J. Mol. Biol."},{"key":"BFnchem2129_CR50","unstructured":"Maestro, version 9.3, Schr\u00f6dinger Release 2014\u20132 (Schr\u00f6dinger LLC, New York, 2014)."}],"container-title":["Nature Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nchem.2129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nchem.2129","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nchem.2129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T16:06:47Z","timestamp":1684426007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nchem.2129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,8]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["BFnchem2129"],"URL":"https:\/\/doi.org\/10.1038\/nchem.2129","relation":{},"ISSN":["1755-4330","1755-4349"],"issn-type":[{"value":"1755-4330","type":"print"},{"value":"1755-4349","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,8]]},"assertion":[{"value":"4 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}